CUV 2.95% $13.17 clinuvel pharmaceuticals limited

anyone else see the august presentation, page-2

  1. 3,045 Posts.
    Check out the follow up interview, seems on track especially given Phase I in the US is due for completion by December and Phase III trials there after.

    I don't see anything negative, perhaps some posters that know the stock better can look for hints on progress. This time next year it should be a different company.

    I'm holding.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$13.17
Change
-0.400(2.95%)
Mkt cap ! $665.5M
Open High Low Value Volume
$13.46 $13.57 $13.13 $556.7K 42.04K

Buyers (Bids)

No. Vol. Price($)
7 167 $13.17
 

Sellers (Offers)

Price($) Vol. No.
$13.19 180 11
View Market Depth
Last trade - 13.23pm 22/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.